Morgan Stanley Organon & Co. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Organon & Co. stock. As of the latest transaction made, Morgan Stanley holds 5,118,194 shares of OGN stock, worth $75.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,118,194

Previous 5,301,779 3.46%

Holding current value

$75.4 Million

Previous $110 Million 10.78%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$18.65 - $23.03 $3.42 Million - $4.23 Million	-183,585 Reduced 3.46%	5,118,194 $97.9 Million
Q2 2024 Oct 17, 2024	BUY	$17.45 - $21.96 $4.59 Million - $5.77 Million	262,959 Added 5.22%	5,301,779 $110 Million
Q2 2024 Aug 14, 2024	BUY	$17.45 - $21.96 $4.59 Million - $5.77 Million	262,959 Added 5.22%	5,301,779 $110 Million
Q1 2024 Oct 17, 2024	SELL	$13.78 - $18.8 $3.62 Million - $4.94 Million	-262,959 Reduced 4.96%	5,038,820 $94.7 Million
Q1 2024 Aug 16, 2024	SELL	$13.78 - $18.8 $11.3 Million - $15.4 Million	-820,208 Reduced 14.0%	5,038,820 $94.7 Million
Q1 2024 May 15, 2024	SELL	$13.78 - $18.8 $11.3 Million - $15.4 Million	-820,208 Reduced 14.0%	5,038,820 $94.7 Million
Q4 2023 Aug 16, 2024	BUY	$10.95 - $17.32 $6.1 Million - $9.65 Million	557,249 Added 10.51%	5,859,028 $84.5 Million
Q4 2023 Feb 13, 2024	BUY	$10.95 - $17.32 $30.9 Million - $48.9 Million	2,823,591 Added 93.02%	5,859,028 $84.5 Million
Q3 2023 Nov 15, 2023	BUY	$16.59 - $23.77 $5.23 Million - $7.5 Million	315,464 Added 11.6%	3,035,437 $52.7 Million
Q2 2023 Aug 14, 2023	BUY	$19.27 - $24.63 $1.02 Million - $1.3 Million	52,724 Added 1.98%	2,719,973 $56.6 Million
Q1 2023 May 15, 2023	SELL	$21.42 - $32.08 $7.4 Million - $11.1 Million	-345,610 Reduced 11.47%	2,667,249 $62.7 Million
Q4 2022 Feb 14, 2023	SELL	$23.31 - $28.61 $313,286 - $384,518	-13,440 Reduced 0.44%	3,012,859 $84.2 Million
Q3 2022 Nov 14, 2022	BUY	$23.4 - $34.25 $526,874 - $771,173	22,516 Added 0.75%	3,026,299 $70.8 Million
Q2 2022 Oct 27, 2022	BUY	$31.66 - $38.9 $32 Million - $39.4 Million	1,011,902 Added 50.8%	3,003,783 $101 Million
Q2 2022 Aug 15, 2022	BUY	$31.66 - $38.9 $32 Million - $39.4 Million	1,011,902 Added 50.8%	3,003,783 $101 Million
Q1 2022 Oct 27, 2022	SELL	$30.45 - $39.36 $30.8 Million - $39.8 Million	-1,011,902 Reduced 33.69%	1,991,881 $69.6 Million
Q1 2022 May 13, 2022	BUY	$30.45 - $39.36 $4.21 Million - $5.44 Million	138,203 Added 7.46%	1,991,881 $69.6 Million
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $4.17 Million - $5.41 Million	-145,572 Reduced 7.28%	1,853,678 $56.4 Million
Q3 2021 Nov 15, 2021	BUY	$28.63 - $35.64 $57.2 Million - $71.3 Million	1,999,250 New	1,999,250 $65.6 Million

Others Institutions Holding OGN

# of Institutions

791

Shares Held

193M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account